VIMZARIO
Live / Allowed — Approved for publication (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99331135
- Mark type
- Stylized text
- Filed
- 11 Aug 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; preparations for medical purposes
Owner
- Juno Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 01 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 06 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 06 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 06 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 19 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Nov 2025 — NON-FINAL ACTION E-MAILED
- 19 Nov 2025 — NON-FINAL ACTION WRITTEN
- 12 Nov 2025 — ASSIGNED TO EXAMINER
- 11 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 11 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Aug 2025 — NEW APPLICATION ENTERED